Highlights Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:27 2025-06-13 am EDT			5-day change	1st Jan Change
318.00 ^EUR	-0.31%		-2.30%	+0.47%

Apr. 16	VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway
Apr. 16	VIRBAC : Stifel still buying after Q1 results	CF

Highlights

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway	Apr. 16
VIRBAC : Stifel still buying after Q1 results	Apr. 16	CF
French and Benelux stocks-Factors to watch	Apr. 16	RE
Virbac: Q1 sales up 8.5%	Apr. 15	CF
Virbac Q1 Revenue EUR 375.2 Million	Apr. 15	RE
Virbac SA Seeks Acquisitions	Mar. 14	CI
French and Benelux stocks-Factors to watch	Mar. 14	RE
Virbac: 20% increase in consolidated net income by 2024	Mar. 13	CF
Virbac Eyes 2025 Revenue Growth Between 4% And 6%	Mar. 13	RE
Virbac SA Provides Financial Guidance for the Fiscal 2025	Mar. 13	CI
Virbac SA Recommends Dividend Distribution for the 2024	Mar. 13	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 12	CI
VIRBAC : 2024 top-line goals met; uninspiring 2025 outlook could be raised later	Jan. 17
Oddo BHF Downgrades Virbac to Neutral, Cuts PT	Jan. 17	MT
Virbac forecasts sales growth of 4 to 6% in 2025	Jan. 16	RE
Virbac SA Provides Revenue Guidance for the Year 2025	Jan. 16	CI
Virbac SA Reports Non-Audited Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 2024	Jan. 16	CI
A poor 2024 increases the odds of a brighter 2025	Jan. 02
Virbac SA's Equity Buyback announced on December 19, 2024 has expired.	Dec. 18	CI
Virbac Buys Turkish Animal Health Product Distributor Mopsan	Dec. 03	MT
Virbac SA acquired Mopsan Veteriner Urunleri A.S.	Dec. 02	CI
VIRBAC : Market’s anxiety over the Q3 miss was not warranted	24-10-18
VIRBAC : Making good strides	24-10-01
Virbac SA Raises Earnings Guidance for the Fiscal Year 2024	24-09-16	CI
Virbac SA Reports Earnings Results for the Half Year Ended June 30, 2024	24-09-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway

April 16, 2025 at 07:58 am EDT